Michael T. Campoli

Mike’s broad-based practice includes counseling clients concerning securities law compliance, Securities Exchange Act reporting, corporate formation and governance, mergers + acquisitions, public and private debt and equity financing, joint ventures, limited liability companies, and partnerships.

Clients ranging from biotech firms to media and entertainment companies seek Mike’s representation at all stages of their businesses’ life cycles. Whether advising on financial investments to fuel startups or counseling mature companies on vital business opportunities, he is committed to finding creative solutions that fit real-world objectives. He closely monitors trends in capital formation – especially investments related to crowdfunding and the JOBS Act – in order to provide sound, strategic guidance.

Helping Companies Close Important Deals

With Mike’s counsel, many companies have achieved important strategic milestones, raised capital, made strategic financial investments and expanded through mergers and acquisitions. Highlights of his work include:

• Cetus Capital Acquisition Corp. (Nasdaq: CETU), a special purpose acquisition company, in connection with SPAC formation matters, its $67.5 million initial public offering, and its de-SPAC merger with MKDWELL Tech, Inc. (Nasdaq: MKDW).
• Minority Equality Opportunities Acquisition Inc. (Nasdaq: MEOA), a special purpose acquisition company, and its Sponsor, Sphere 3D Corp. (Nasdaq: ANY), in connection with SPAC formation matters, its $126 million initial public offering, and its de-SPAC merger with Digerati Technologies, Inc.
• Suma Brands, Inc. (d/b/a The Ambr Group), an Amazon aggregator, in connection with its acquisition of Profound Commerce, Inc., and D1 Brands, Inc., an Amazon aggregator, in connection with its acquisition by Suma Brands, Inc. (d/b/a The Ambr Group).
• Soleus Capital Group in connection with its investments in numerous public and private biotech and healthcare companies, including BioAtla, Inc., Harpoon Therapeutics, Inc., VYNE Therapeutics, Inc., Inhibikase, Inc., Glycomimetics., Inc. and Jade Biosciences, Inc.
• Early-stage companies such as Dadi Inc. (a male fertility and sperm-testing startup that was acquired by Ro), PayGo Energy, Inc. (a Nairobi-based clean cooking technology startup that was acquired by Sun King, the largest off-grid energy company in Africa and Asia), and Pack Labs, Inc. (a developer and distributor of beverage products) for organizational matters, seed and venture financing, mergers + acquisitions, and other general corporate matters.
• Roth Capital Partners, LLC, Maxim Group LLC and EF Hutton in various underwritten initial and follow-on public offerings, private offerings, and hybrid offerings for domestic and foreign issuers.
• Adhera Therapeutics, Inc., a leading nucleic acid-based drug discovery and development company, on securities, capital raising, mergers + acquisitions, licensing agreements, debt offerings, and general corporate matters.
• Complex M+A transactions for clients such as Henry Schein, Inc. (Nasdaq: HSIC), AVM Software, Inc. (in connection with its reverse acquisition of Paltalk, Inc. (Nasdaq: PALT)) and Wolters Kluwer.
• KBL Merger Corp. IV in connection with its de-SPAC merger with 180 Life Sciences Corp.